Kristie L. Kahl

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about the differences between genetic and genomic testing in breast cancer care.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about personalized therapy in breast cancer care.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about side effect management in breast cancer care.

As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about prognostic and predictive outcomes in breast cancer, and the options available as a result.

As part of its Speaking Out video series, CURE spoke with Juanita Miller, an ANGEL Advocate from the Tigerlily Foundation, about fear of recurrence after breast cancer.

Watch Dr. Rami Komrokji and Dr. John O. Mascarenhas answer questions about myelofibrosis during the CURE® Educated Patient® MPN Summit.

Watch Dr. Nikolai Podoltsev, Dr. Jerry Spivak and Amy Lane answer questions about polycythemia vera during the CURE® Educated Patient® MPN Summit.

Watch Dr. Lucia Masarova, Dr. Laura C. Michaelis and Celia Militz answer questions about essential thrombocythemia during the CURE® Educated Patient® MPN Summit.

Maintenance Darzalex, with or without Pomalyst was safe and efficacious in treating patients with relapsed myeloma who underwent salvage autologous hematopoietic stem cell transplant.

Meaningful improvements in survival were obtained with Zejula maintenance therapy compared with placebo in patients with advanced ovarian cancer that was newly diagnosed.

Tumor treating fields therapy “is a potentially paradigm-shifting new treatment modality” for metastatic non-small cell lung cancer, says Dr. Ticiana Leal.

As part of its Speaking Out video series, CURE spoke with Monica Fawzy Bryant, Esq., from Triage Cancer, about how to better manage medical bills following a cancer diagnosis.

As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about working during a cancer diagnosis and its treatments, and what rights individuals have when it comes to employment and insurance.

As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about policies around taking extended time off from work for patients with cancer and their caregivers.

As part of its Speaking Out video series, CURE spoke with Monica Fawzy Bryant, Esq.,, from Triage Cancer, about planning ahead after a cancer diagnosis.

Watch Dr. Jyoti Malhotra and Ken Culver answer questions about the future of the disease during the CURE® Educated Patient® Lung Cancer Summit.

Watch Dr. Ed Kim, Dr. Jyoti Malhotra and Terri Conneran answer questions about targeted therapy during the CURE® Educated Patient® Lung Cancer Summit.

Watch Dr. Thomas Waddington and Dr. Percy Lee answer questions about diagnostic and radiation advances during the CURE® Educated Patient® Lung Cancer Summit.

A dose reduction of Erleada may result in fewer skin-related side effects for men with advanced prostate cancer — but only for those with a smaller body size, research showed.

Men with metastatic hormone-sensitive prostate cancer treated with Nubeqa, androgen-deprivation therapy and docetaxel had reductions in PSA levels that were associated with improved overall survival and a prolonged time to PSA progression.

Watch Dr. Brandon J Blue, Dr. Surbhi Sidana, Dr. Kenneth H. Shain and Mary Derome answer questions about the future of treatment during the CURE Educated Patient Multiple Myeloma Summit.

Watch Dr. Brandon J Blue, Dr. Dickran Kazandjian and Dr. Marc J. Braunstein answer questions about disease management during the CURE Educated Patient Multiple Myeloma Summit.

Watch Dr. Ariel Grajales-Cruz and Dr. Brandon J Blue answer questions about myeloma during the CURE Educated Patient Multiple Myeloma Summit.

In this Educated Patient® webinar, CURE® spoke with experts from Allegheny Health Network about addressing disparities in diversity, equity and inclusion in cancer care.

Watch Dr. Susan Domchek, Dr. Debu Tripathy and Dr. Jennifer Gass answer questions about precision medicine during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Watch Dr. William J Gradishar, Dr. Kevin Kalinsky and Kelly Thomas answer questions about hormone receptor-positive and triple-negative breast cancer treatment options during the CURE Educated Patient® Breast Cancer Summit at MBCC.

Patients who used opioids long-term after undergoing an autologous stem cell transplant tended to have poorer survival outcomes, recent research showed.

As part of its Speaking Out video series, CURE® spoke with Michael J. Rovito, on behalf of the Testicular Cancer Foundation, about survivorship.

Watch Dr. Aaron Gerds and Dr. Andrew Kuykendall answer questions about myelofibrosis during the CURE Educated Patient MPN Summit.

Watch Dr. Jamile Shammo and Dr. John Mascarenhas answer questions about polycythemia vera during the CURE Educated Patient MPN Summit.